Page 153 - Vitamin D and Cancer

140 R. Scragg

157. Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis
of randomized controlled trials. Arch Intern Med 167:1730–1737
158. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford
SA, Black HR, Blanchette P et al (2006) Calcium plus vitamin D supplementation and the
risk of fractures. N Engl J Med 354:669–683
159. Giovannucci E (2007) Can vitamin D reduce total mortality? Arch Intern Med
167:1709–1710
160. Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake
exceeding the lowest observed adverse effect level. Am J Clin Nutr 73:288–294
161. Beaglehole R, Magnus P (2002) The search for new risk factors for coronary heart disease:
occupational therapy for epidemiologists? Int J Epidemiol 31:1117–1122, author reply
1134–1115
162. Ross R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340:115–126
163. Hansson GK, Libby P, Schonbeck U, Yan ZQ (2002) Innate and adaptive immunity in the
pathogenesis of atherosclerosis. Circ Res 91:281–291
164. Rao M, Jaber BL, Balakrishnan VS (2006) Inflammatory biomarkers and cardiovascular
risk: association or cause and effect? Semin Dial 19:129–135
165. Tousoulis D, Antoniades C, Koumallos N, Stefanadis C (2006) Pro-inflammatory cytokines
in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev
17:225–233
166. Cardaropoli S, Silvagno F, Morra E, Pescarmona GP, Todros T (2003) Infectious and inflam-
matory stimuli decrease endothelial nitric oxide synthase activity in vitro. J Hypertens
21:2103–2110
167. Khoshdel AR, Carney SL, Nair BR, Gillies A (2007) Better management of cardiovascular
diseases by pulse wave velocity: combining clinical practice with clinical research using
evidence-based medicine. Clin Med Res 5:45–52
168. Newby AC (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening
and atherosclerotic plaque rupture. Physiol Rev 85:1–31
169. Loftus IM, Thompson MM (2002) The role of matrix metalloproteinases in vascular disease.
Vasc Med 7:117–133
170. Perlstein TS, Lee RT (2006) Smoking, metalloproteinases, and vascular disease. Arterioscler
Thromb Vasc Biol 26:250–256
171. Turk S, Akbulut M, Yildiz A, Gurbilek M, Gonen S, Tombul Z, Yeksan M (2002)
Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis
patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron
90:188–194
172. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack
SW (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-
alpha, in vivo. J Clin Endocrinol Metab 82:4196–4200
173. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B (2000)
Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of
obese women after weight loss. J Clin Endocrinol Metab 85:3338–3342
174. Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2
diabetes. Diabetes Care 27:813–823
175. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C (2007) Monocytes
from type 2 diabetic patients have a pro-inflammatory profile. 1, 25-Dihydroxyvitamin D(3)
works as anti-inflammatory. Diabetes Res Clin Pract 77:47–57
176. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K,
Meinken C et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimi-
crobial response. Science 311:1770–1773
177. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ (2007) Vitamin D in the treatment
of pulmonary tuberculosis. J Steroid Biochem Mol Biol 103:793–798
178. Stroder J, Kasal P (1970) Phagocytosis in vitamin D deficient rickets. Klin Wochenschr
48:383–384